Learn how to stay active if you have advanced Parkinson’s, with safe exercises that improve mobility, mood, and sleep.

Reduce fall risk in advanced Parkinson's with physical therapy, home modifications, and smart tech. Stay safe and mobile with expert tips from neurologists.

Global collaboration, the future of patient care, and artificial intelligence (AI) were at the center of the 19th World Federation of Occupational Therapists (WFOT) Congress, held in early February in ...

University of Colorado-Boulder Speech, Language & Hearing Sciences is partnering with LSVT Global to host a LSVT LOUD Virtual Live Training and Certification Course on March 27-28, 2026! The Virtual ...

Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...

Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to-treat diseases, including for rare genetic conditions that the ...

‘No one gets in trouble for accommodating,” an administrator at a top university told me. He was describing a case in which a student requested extended deadlines and modified grading for anxiety. The ...

Jennifer Witte, certified speech-language pathologist (SLP) at Parkview-Bryan Hospital, served as guest speaker March 9 at Parkview-Montpelier Hospital Auxiliary’s noon soup and salad luncheon meeting ...

FDA proposes using a well-supported mechanistic rationale plus natural history comparators to generate substantial evidence when randomized trials are infeasible for ultra-rare populations.

The Food and Drug Administration (FDA) announced a new proposal Monday for flexible drug approval pathway treatments addressing ultrarare diseases. The FDA unveiled draft guidance on a proposed ...

After teasing a new regulatory process for personalized genetic medicines at the end of last year, the FDA today unveiled draft guidance for an approval pathway that could see custom CRISPR therapies, ...

Japan’s health ministry has endorsed issuing conditional approval for two first-of-a-kind medicines. But some researchers say that the therapies — made from reprogrammed stem cells and called Amchepry ...